Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Zekaver Odabasi is active.

Publication


Featured researches published by Zekaver Odabasi.


Emerging Infectious Diseases | 2004

Crimean-Congo hemorrhagic fever in Turkey.

S. Sami Karti; Zekaver Odabasi; Volkan Korten; Mustafa Yilmaz; Mehmet Sonmez; Rahmet Caylan; Elif Akdogan; Necmi Eren; Iftihar Koksal; Ercument Ovali; Bobbie R. Erickson; Martin J. Vincent; Stuart T. Nichol; James A. Comer; Pierre E. Rollin; Thomas G. Ksiazek

Nineteen cases of suspected Crimean-Congo hemorrhagic fever reported from Turkey.


Medical Mycology | 2006

Differences in beta-glucan levels in culture supernatants of a variety of fungi.

Zekaver Odabasi; Victor L. Paetznick; Jose R. Rodriguez; Enuo Chen; Michael R. McGinnis; Luis Ostrosky-Zeichner

(1-->3)-beta-d-glucan is a well known cell wall constituent of fungal isolates that can be detected by assays in vivo and in vitro. Previous studies have shown that different fungal isolates may show different levels of reactivity with an assay for beta glucan. In this study we evaluated the in vitro reactivity of 127 clinical fungal isolates belonging to 40 different genera, with the Glucatell assay. The majority of the fungal isolates released high levels of beta glucan. Beta glucan test reactivity appears to be species-specific and this may reflect the beta glucan content of the organism.


Antimicrobial Agents and Chemotherapy | 2007

Effects of Serum on In Vitro Susceptibility Testing of Echinocandins

Zekaver Odabasi; Victor L. Paetznick; John H. Rex; Luis Ostrosky-Zeichner

ABSTRACT The effects of protein binding on the activities of caspofungin, anidulafungin, and micafungin were evaluated against Candida and Aspergillus species. Adding human serum sharply increased the MICs of micafungin and anidulafungin and modestly affected the MIC of caspofungin. The increase in MICs does not appear consistent with the rate of protein binding for the three compounds.


Nephrology Dialysis Transplantation | 2011

Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: relation with inflammation

Mehmet Koc; Ahmet Toprak; Hakki Arikan; Zekaver Odabasi; Yesim Elbir; Aysin Tulunay; Ebru Asicioglu; Emel Eksioglu-Demiralp; Griet Glorieux; Raymond Vanholder; Emel Akoglu

BACKGROUND Inflammation is one of the main contributors to atherosclerosis in haemodialysis (HD) patients. Activation of Toll-like receptors (TLRs) leads to inflammatory response. In this study, we aimed to evaluate the expression of TLRs on monocytes and relate their expression with inflammation in chronic kidney disease (CKD) and HD patients. METHODS Thirty-four age- and gender-matched controls and stage 3-4 CKD patients and thirty-two HD patients were included in each study group. The effect of HD on the expression of Toll-like receptor-2 (TLR-2) and Toll-like receptor-4 (TLR-4) on CD14( +) monocytes was determined at the beginning (baseline), during (120 min) and following (300 min and 24 h) HD and compared with control and stage 3-4 CKD groups. The HD procedure was performed by using low-flux polysulphone dialysers. In addition, serum IL-6 levels were evaluated in both groups at baseline and after a HD session. RESULTS The percentage of CD14( +) monocytes expressing TLR-2 were similar in all of the study groups, whereas the percentage of CD14( +) monocytes expressing TLR-4 were significantly lower in both stage 3-4 CKD and HD patients at baseline than in controls. The mean fluorescence intensities (MFI) of TLR-2 were significantly lower in controls than in stage 3-4 CKD and HD patients at baseline. The MFI of TLR-4 was similar in all of the groups. The percentage of CD14( +) monocytes expressing TLR-2 did not change during and after HD. The MFI of TLR-2 decreased at 120 min of HD compared with baseline (1837 ± 672 vs 1650 ± 578, P < 0.05), and recovered back to baseline values at 300 min and at 24 h post-HD. MFI of TLR-4 increased at 24 h compared with baseline (941 ± 294 vs 1087 ± 441, P < 0.05). Serum IL-6 levels correlated with MFI of TLR-2 and TLR-4 in stage 3-4 CKD patients and in HD patients at baseline and after HD in univariate analysis. Stepwise multiple regression analysis revealed that MFI of TLR-2 was an independent determinant of serum IL-6 concentrations in stage 3-4 CKD and in HD patients at baseline, at 300 min and at 24 h post-HD. Conclusions. Our study demonstrates that TLR-2 is associated with the inflammatory response of non-dialysed and dialysed CKD patients.


Annals of Clinical Microbiology and Antimicrobials | 2011

Unusual causes of peritonitis in a peritoneal dialysis patient: Alcaligenes faecalis and Pantoea agglomerans

Arzu Kahveci; Ebru Asicioglu; Elif Tukenmez Tigen; Elif Ari; Hakki Arikan; Zekaver Odabasi; Cetin Ozener

An 87 -year-old female who was undergoing peritoneal dialysis presented with peritonitis caused by Alcaligenes faecalis and Pantoea agglomerans in consecutive years. With the following report we discuss the importance of these unusual microorganisms in peritoneal dialysis patients.


Antimicrobial Agents and Chemotherapy | 2009

Reduction of Amphotericin B-Induced Renal Tubular Apoptosis by N-Acetylcysteine

Zekaver Odabasi; A. Karaalp; H. Cermik; J. Mohr; E. T. Tigen; M. Koc; V. Korten

ABSTRACT The reduction of amphotericin B (AmB)-induced renal tubular apoptosis and nephrotoxicity by N-acetylcysteine (NAC) in a murine model was evaluated. Four groups of rats were treated with AmB for 5 days, and each group concomitantly received two doses of 30, 60, or 120 mg of NAC/kg of body weight/day or sterile water for 5 days. Groups that received concomitant NAC at any dose had significantly decreased levels of apoptosis compared to that in animals receiving AmB only (48.8% versus 27.4, 23.6, or 23.5%, respectively; P < 0.001).


Urology | 2014

Outcomes of fecal carriage of extended-spectrum β-lactamase after transrectal ultrasound-guided biopsy of the prostate.

Elif Tukenmez Tigen; Zafer Tandogdu; Onder Ergonul; Gulsen Altinkanat; Bilal Gunaydin; Mahir Bülent Özgen; Nevin Sariguzel; Buket Erturk Sengel; Zekaver Odabasi; Mete Cek; Resit Tokuc; Levent Türkeri; Lutfiye Mulazimoglu; Volkan Korten

OBJECTIVE To determine the prevalence of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae (PE) fecal carriage in patients that undergo transrectal ultrasonography-guided biopsy (TRUSbx) and its relationship with post-biopsy infections. METHODS A prospective clinical study in 4 different tertiary hospitals between 2008 and 2010 was conducted. Four hundred men with sterile urine who were to undergo a TRUSbx because of the suspicion of prostate cancer were included and followed for 14 days after biopsy. Rectal swab culture specimens were acquired immediately before the procedure. Demographic data, prophylaxis choice, quinolone or any other antibiotic consumption within the past 2 months, history of prostatitis, repeat biopsy, intensive care unit admission, hospitalization, urethral catheterization, diabetes mellitus (DM), and steroid usage were recorded. RESULTS ESBL carriage was detected in 19% of patients and quinolone use within the last 2 months; other antibiotic use within the last 2 months and DM were found to be significantly associated (P <.05). Symptomatic urinary tract infection (UTI) on the third day after biopsy was seen in 9% of patients and was associated with fluoroquinolone (FQ) consumption before biopsy. Although ESBL-PE carriage was associated with post-biopsy UTI symptoms, it was not found to be associated with post-biopsy symptomatic UTI. Urosepsis was seen in 2 patients (0.5%) after biopsy, and both the patients were ESBL-PE carriers. CONCLUSION The presence of ESBL-PE was associated with DM and FQ consumption before biopsy. ESBL-PE carriage was associated with a high rate of post-biopsy UTI symptoms requiring further elucidation; however, it was not associated with microbiologically proven infections. FQ consumption before TRUSbx was also associated with post-biopsy infections.


Case reports in infectious diseases | 2015

Miliary Tuberculosis Induced Acute Liver Failure

Tayfur Toptas; Birkan Ilhan; Huseyin Bilgin; Elif Dincses; Osman Ozdogan; Isik Kaygusuz-Atagunduz; Zekaver Odabasi; Volkan Korten; Tulin Firatli-Tuglular

Hepatobiliary tuberculosis is uncommon even in endemic countries. It is associated with a high mortality and is even diagnosed early in the disease course. Acute liver failure (ALF) caused by tuberculosis bacilli has been reported in only a few reports. All previous cases have been diagnosed by postmortem examination. Time to antituberculosis treatment is very critical. In case of suggestive findings on clinical and radiologic examination, antituberculosis treatment should be initiated immediately. Drug use can be a challenge in patients with ALF. However, as long as the other possible causes of ALF can be excluded and hepatotoxic drugs were avoided during the early course of treatment, such a highly fatal presentation of tuberculosis can be treated safely. Here, we report a case of acute liver failure as a presentation of miliary tuberculosis. He was treated successfully with antituberculosis treatment.


European journal of general medicine | 2006

STREPTOCOCCUS BOVIS ENDOCARDITIS ASSOCIATED WITH RECTAL CARCINOMA AND ITS NEUROLOGICAL COMPLICATIONS CASE REPORT AND LITERATURE REVIEW

Yasin Abul; Zekaver Odabasi; Nihat Kodalli; Ahmet Oktay; Volkan Korten


Archive | 2016

Efficacy of N-acetylcysteine in preventing amphotericin B induced acute kidney injury Amfoterisin-B ilişkili akut böbrek hasarini önlemede N-asetilsistein'in etkisi

Buket Erturk Sengel; Elif Tukenmez Tigen; Tayfur Toptas; Isik Kaygusuz Atagunduz; Ayse Tulin Tuglular; Mehmet Onder Ergönül; Zekaver Odabasi

Collaboration


Dive into the Zekaver Odabasi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge